Opposing roles of the two isoforms of ErbB3 binding protein 1 in human cancer cells

被引:22
|
作者
Ko, Hyo Rim [1 ]
Chang, Yun Sil [2 ]
Park, Won Soon [2 ]
Ahn, Jee-Yin [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol,Ctr Mol Med, Suwon, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, 81 Irwonro, Seoul 06351, South Korea
关键词
Ebp1; oncogene; tumor suppressor gene; MEDIATED TRANSCRIPTION; LONG ISOFORM; EBP1; GROWTH; PHOSPHORYLATION; PROLIFERATION; EXPRESSION; REPRESSION; DIFFERENTIATION; IDENTIFICATION;
D O I
10.1002/ijc.30165
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The different functions of the two isoforms of ErbB3 binding protein 1 (Ebp1), p48 and p42, have recently become the focus of interest as they reveal contradictory roles in cell growth promoting ability. The conformational change that crystal structure of p42 was shown to lack a helices at the amino-terminus present in p48 represents the differential binding partners and protein modifications of two Ebp1 isoforms. N-terminal specific phosphorylation by CDK2 and deregulation of the p53 tumor suppressor through specific interaction with HDM2 and Akt activation is postulated to contribute to p48-mediated tumorigenesis. The short isoform p42 Ebp1, which is actual binding partner of ErbB3 has been implicated as a tumor suppressor with many binding partners such as Rb, HDAC2, Sin3A and the p85 subunit of PI3K with HSP70/CHIP, inhibiting its own antiproliferative activity or inhibiting PI3K activity. The aim of the current review is to provide a summary on distinctive cellular functions of two Ebp1 proteins and their molecular partners that might be responsible for the unique functions of each isoform of Ebp1.
引用
收藏
页码:1202 / 1208
页数:7
相关论文
共 50 条
  • [41] The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition
    Ma, Elise L.
    Choi, Yoon Jeong
    Choi, Jinyoung
    Pothoulakis, Charalabos
    Rhee, Sang Hoon
    Im, Eunok
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (04) : 780 - 790
  • [42] The regulation of nuclear ErbB3 by the androgen receptor in prostate cancer cells.
    Jathal, M. K.
    Steele, T. M.
    Siddiqui, S.
    Ghosh, P. M.
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [43] Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells
    Liu, Bolin
    Ordonez-Ercan, Dalia
    Fan, Zeying
    Edgerton, Susan M.
    Yang, XiaoHe
    Thor, Ann D.
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (09) : 1874 - 1882
  • [44] Down-regulation of ErbB2 and ErbB3 levels by curcumin in MCF-7 human breast cancer cells
    Yi, SH
    Park, JHY
    FASEB JOURNAL, 2004, 18 (04): : A126 - A126
  • [45] Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance
    Sun, Jian
    Luo, Yixi
    Tian, Zhen
    Gu, Liang
    Xia, Shu Chi
    Yu, Youcheng
    BMC CANCER, 2012, 12
  • [46] Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling
    Zhang, Y
    Hamburger, AW
    BRITISH JOURNAL OF CANCER, 2005, 92 (01) : 140 - 146
  • [47] Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance
    Jian Sun
    Yixi Luo
    Zhen Tian
    Liang Gu
    Shu Chi Xia
    Youcheng Yu
    BMC Cancer, 12
  • [48] Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling
    Y Zhang
    A W Hamburger
    British Journal of Cancer, 2005, 92 : 140 - 146
  • [49] Inorganic sulfur reduces cell proliferation by inhibiting of ErbB2 and ErbB3 protein and mRNA expression in MDA-MB-231 human breast cancer cells
    Ha, Ae Wha
    Hong, Kyung Hee
    Kim, Hee Sun
    Kim, Woo Kyoung
    NUTRITION RESEARCH AND PRACTICE, 2013, 7 (02) : 89 - 95
  • [50] ERBB3 binding protein 1 promotes the progression of malignant melanoma through activation of the Wnt/β-catenin signaling pathway
    Bao, Yanqiu
    Cui, Jingshu
    Yue, Yuyang
    Cao, Shuxia
    Li, Xiangdan
    Liu, Lan
    CANCER CELL INTERNATIONAL, 2022, 22 (01)